
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1053 | 999 | 1000 | 936 | 1224 | 1399 |
Fund Return | 5.32% | -0.1% | 0.02% | -2.19% | 4.13% | 3.41% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LGeneration Global EUR P D | 1.64B | 5.78 | 6.48 | 11.81 | ||
LGeneration Global EUR R A | 1.65B | 5.69 | 5.37 | 10.86 | ||
LGeneration Global EUR I | 1.65B | 5.84 | 7.12 | 12.37 | ||
LGeneration Global EUR I Dist | 1.65B | 5.84 | 7.12 | 12.44 | ||
LGeneration Global EUR M A | 1.65B | 5.82 | 6.91 | 12.18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco JapEqAdvantage A EUR H AccE | 63.54B | -1.95 | 10.69 | 6.70 | ||
Invesco JapEqAdvantage C EUR H AccE | 63.54B | -1.82 | 11.66 | 7.54 | ||
LU1482751903 | 439.28M | 1.06 | 12.91 | - | ||
LU1841614867 | 266.63M | 0.91 | 11.92 | - | ||
LU0552899998 | 20.2B | 3.47 | 2.70 | 6.90 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Tapestry | US8760301072 | 3.68 | 71.69 | -0.39% | |
Abbott Labs | US0028241000 | 3.51 | 130.28 | -1.79% | |
Manulife Financial | CA56501R1064 | 3.43 | 29.25 | +2.27% | |
UnitedHealth | US91324P1021 | 3.20 | 481.11 | -1.01% | |
Ameriprise Financial | US03076C1062 | 3.01 | 480.46 | +0.50% |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
Technical Indicators | Sell | Sell | Sell | Sell | Sell |
Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review